- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05737225
Regional Anesthesia for Percutaneous Transluminal Angioplasty
December 19, 2023 updated by: Demet Coşkun, Gazi University
The Effect of Regional Anesthesia Method on Tissue Oxygenation in Patients Who Will Undergo Percutaneous Transluminal Angioplasty
In this study, the effects of regional anesthesia method applied in patients who will undergo percutaneous transluminal angioplasty for lower extremity revascularization will be investigated comparatively.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
70
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey, 06490
- Gazi University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
ASA I-III patients over the age of 18 who have been decided to perform elective PTA as a treatment method for peripheral arterial disease will be included in the study.
Description
Inclusion Criteria:
- Age: > 18 years
- Peripheral artery occlusive disease
- Eligibility for PTA
Exclusion Criteria:
- Patients' refusal
- Under the age of 18
- Language problems (not knowing turkish)
- Psychological or mental disorders.
- Disturbance of Conscious level.
- Uncooperative patients
- Those who are allergic to anesthetic drugs to be used
- Those with contraindications for the application of peripheral nerve block (coagulopathy, skin infection at the block site)
- need for endotracheal intubation or general anesthesia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Popliteal sciatic nerve block group
regional anesthesia applied patients who will undergo percutaneous transluminal angioplasty (PTA) procedure
|
We will place Near Infrared Spectroscopy (NIRS) electrode on the foot to evaluate regional tissue oxygen saturation in both lower extremities before the performing regional anesthesia (popliteal sciatic nerve block) and then during the procedure.
|
|
Control group
patients who will undergo percutaneous transluminal angioplasty (PTA) procedure
|
We will place Near Infrared Spectroscopy (NIRS) electrode on the foot to evaluate regional tissue oxygen saturation in both lower extremities before the performing regional anesthesia (popliteal sciatic nerve block) and then during the procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tissue Oxygenation
Time Frame: During procedure
|
Tissue oxygenation will be measured from both lower extremities by Near Infrared Spectroscopy for 30 min after popliteal sciatic nerve block and during procedure.
|
During procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Temperature of Lower Extremities
Time Frame: During procedure
|
Body temperature will be measured simultaneously at 0-5-10-15-20-25 and 30th minutes after the application of the popliteal sciatic nerve block
|
During procedure
|
|
Patient Satisfaction Score
Time Frame: 15 minutes after procedure
|
Self-administrated satisfaction score will be collected with scale from 0 to 5. A score of "0" means extremely dissatisfied and that a score of "5" means extremely satisfied.
|
15 minutes after procedure
|
|
Surgeon Satisfaction Score
Time Frame: 15 minutes after procedure
|
Self-administrated satisfaction score will be collected with scale from 0 to 5. A score of "0" means extremely dissatisfied and that a score of "5" means extremely satisfied.
|
15 minutes after procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 24, 2022
Primary Completion (Actual)
April 17, 2023
Study Completion (Actual)
May 1, 2023
Study Registration Dates
First Submitted
February 3, 2023
First Submitted That Met QC Criteria
February 19, 2023
First Posted (Actual)
February 21, 2023
Study Record Updates
Last Update Posted (Estimated)
December 20, 2023
Last Update Submitted That Met QC Criteria
December 19, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 775 (24.10.2022)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Percutaneous Transluminal Angioplasty
-
Klinik für Kardiologie, Pneumologie und AngiologieRecruiting
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaTerminatedPercutaneous Transluminal Coronary AngioplastySouth Korea
-
Samsung Medical CenterUnknownAngioplasty, Transluminal, Percutaneous CoronaryKorea, Republic of
-
SanofiCompletedAngioplasty, Transluminal, Percutaneous CoronaryUnited States, Spain, Belgium, Canada, South Africa, Netherlands, Germany, France, Czech Republic, Slovakia
-
Ospedale della MisericordiaUnknownTo Achieve an Early Reendothelialization at the Expense of Low Restenosis: The EREMUS Study (EREMUS)Percutaneous Coronary Intervention | Angioplasty, Transluminal, Percutaneous CoronaryItaly
-
Centocor, Inc.CompletedAngioplasty, Transluminal, Percutaneous Coronary
-
Università degli Studi di FerraraCompletedAngioplasty, Transluminal, Percutaneous CoronaryItaly
-
Policlinico Casilino ASL RMBCompletedAngioplasty, Transluminal, Percutaneous Coronary | Coronary AngiographyItaly
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaTerminatedPercutaneous Transluminal Coronary AngioplastyKorea, Republic of
-
October 6 UniversityCompletedPercutaneous Transluminal Coronary AngioplastyEgypt
Clinical Trials on Near Infrared Spectroscopy (NIRS)
-
Brigham and Women's HospitalUnknownHypoxia | Infant, Premature, Diseases | Necrotizing EnterocolitisUnited States
-
University of UtahIntermountain Health Care, Inc.CompletedNecrotizing Enterocolitis | Congenital Heart Disease | Patent Ductus Arteriosus | Infant, PrematureUnited States
-
Nationwide Children's HospitalCompleted
-
Marmara UniversityUnknownNecrotizing EnterocolitisTurkey
-
University Medical Centre LjubljanaSlovenian Research AgencyCompleted
-
University of AthensTerminatedCOVID-19 Pneumonia | COVID-19 Acute Respiratory Distress SyndromeGreece
-
Centre Hospitalier Universitaire, AmiensCompletedChild | Diagnosis | NIRS | Testicular Torsion | Diagnostic TestFrance
-
Odense University HospitalCompletedMyocardial Infarction | Myocardial Ischemia | Vascular Diseases | Coronary Artery Disease | Atherosclerosis | Lipid-Rich Atherosclerosis of Coronary Artery | Infarct IschemiaDenmark
-
University College, LondonRecruitingCompromised Placental FunctionUnited Kingdom